NIOX Group (LON:NIOX – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 2.27 ($0.03) earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%.
NIOX Group Trading Down 0.8 %
LON:NIOX opened at GBX 74.40 ($0.97) on Thursday. The firm has a 50-day simple moving average of GBX 64.30 and a 200-day simple moving average of GBX 63.95. NIOX Group has a one year low of GBX 57 ($0.74) and a one year high of GBX 80 ($1.04). The firm has a market cap of £30.56 billion, a P/E ratio of 3,070.36 and a beta of 0.92. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31.
Insider Transactions at NIOX Group
In related news, insider Jonathan Emms bought 127,454 shares of the business’s stock in a transaction on Tuesday, April 1st. The shares were bought at an average price of GBX 8 ($0.10) per share, for a total transaction of £10,196.32 ($13,240.25). Corporate insiders own 46.72% of the company’s stock.
About NIOX Group
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Further Reading
- Five stocks we like better than NIOX Group
- Financial Services Stocks Investing
- Equinix: A Smart Bet on Data Centers, Dividends, and AI
- What is the Hang Seng index?
- PVH Stock Is Surging—Here’s What’s Fueling the Rebound
- 3 Healthcare Dividend Stocks to Buy
- Tesla Stock: What To Expect With Their Delivery Numbers Report
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.